IT1254321B - Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. - Google Patents
Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.Info
- Publication number
- IT1254321B IT1254321B ITRM920270A ITRM920270A IT1254321B IT 1254321 B IT1254321 B IT 1254321B IT RM920270 A ITRM920270 A IT RM920270A IT RM920270 A ITRM920270 A IT RM920270A IT 1254321 B IT1254321 B IT 1254321B
- Authority
- IT
- Italy
- Prior art keywords
- prevention
- treatment
- pharmaceutical composition
- oral mucosa
- inflammations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Viene descritta una composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale comprendente l'acido 18b-glicirretico, alcaloidi benzofenantridinici ed eventualmente un adatto sale metallico.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM920270A IT1254321B (it) | 1992-04-10 | 1992-04-10 | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. |
EP93830139A EP0565495A1 (en) | 1992-04-10 | 1993-04-02 | Pharmaceutical composition containing glycyrrhetinic acid and phenanthridine alkaloids |
CA002093401A CA2093401A1 (en) | 1992-04-10 | 1993-04-05 | Pharmaceutical compositions for the treatment and prevention of cutaneous and oral mucous membrane inflammation |
US08/043,493 US5425948A (en) | 1992-04-10 | 1993-04-06 | Pharmaceutical compositions for the treatment and prevention of cutaneous and oral mucous membrane inflammations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM920270A IT1254321B (it) | 1992-04-10 | 1992-04-10 | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM920270A0 ITRM920270A0 (it) | 1992-04-10 |
ITRM920270A1 ITRM920270A1 (it) | 1993-10-10 |
IT1254321B true IT1254321B (it) | 1995-09-14 |
Family
ID=11400944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM920270A IT1254321B (it) | 1992-04-10 | 1992-04-10 | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. |
Country Status (4)
Country | Link |
---|---|
US (1) | US5425948A (it) |
EP (1) | EP0565495A1 (it) |
CA (1) | CA2093401A1 (it) |
IT (1) | IT1254321B (it) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US6902738B2 (en) * | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
WO1996024341A1 (en) * | 1995-02-07 | 1996-08-15 | Narayan Krishnarao Athanikar | Concomitant treatment with bismuth and antibacterials |
GT199700054A (es) * | 1996-05-03 | 1998-10-22 | Pesticidas que contienen alcaloides de benzofenantridina | |
DE19654508C1 (de) * | 1996-12-18 | 1998-08-13 | Lancaster Group Gmbh | Kosmetisches Reinigungs- und Pflegepräparat |
KR100230710B1 (ko) * | 1997-06-26 | 1999-11-15 | 전기영 | 잇몸질환의 예방 및 치료용 조성물 |
US5908640A (en) * | 1997-07-25 | 1999-06-01 | Embro; William J. | Veterinary compositions for treating epidermal irritations |
KR100356697B1 (ko) * | 1998-03-07 | 2002-12-18 | 주식회사 태평양 | 여드름에효과가있는피부용조성물 |
US7151082B2 (en) * | 1999-02-11 | 2006-12-19 | The Feinstein Institute For Medical Research | Antagonists of HMG1 for treating inflammatory conditions |
US6303321B1 (en) * | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
AUPR726701A0 (en) * | 2001-08-24 | 2001-09-20 | HWF Enterprises Pty Ltd | Compound for treatment of lesions and tumours |
ITMI20020756A1 (it) * | 2002-04-09 | 2003-10-09 | Sinclair Pharma S R L | Composizioni farmaceutiche topiche per il trattamento delle dermatiti |
US7696169B2 (en) * | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
CA2538763C (en) * | 2003-09-11 | 2015-05-05 | Critical Therapeutics, Inc. | Monoclonal antibodies against hmgb1 |
WO2007011606A2 (en) * | 2005-07-18 | 2007-01-25 | Critical Therapeutics, Inc. | USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS |
EP1959997A4 (en) * | 2005-11-28 | 2009-12-23 | Medimmune Llc | ANTAGONISTS OF HMGB1 AND / OR RAGE AND METHOD OF USE THEREOF |
WO2009043341A2 (de) * | 2007-10-02 | 2009-04-09 | Kuhs Gmbh | Topisch zu applizierende kosmetische oder pharmazeutische zusammensetzung |
ITMI20080038A1 (it) * | 2008-01-11 | 2009-07-12 | Indena Spa | Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva |
ITMI20080395A1 (it) | 2008-03-10 | 2009-09-11 | Indena Spa | Formulazioni per il trattamento delle verruche e delle placche psoriatiche |
US9676696B2 (en) * | 2009-01-29 | 2017-06-13 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2122893B (en) * | 1982-06-30 | 1985-06-26 | Biorex Laboratories Ltd | Glycyrrhetinic acid compositions |
CA1335076C (en) * | 1987-04-01 | 1995-04-04 | Hanna R. Kowarski | Pharmaceutical composition and method for intranasal administration |
US5175000A (en) * | 1987-06-30 | 1992-12-29 | Vipont Pharmaceutical, Inc. | Free amine benzophenanthridine alkaloid compositions |
NZ232572A (en) * | 1989-03-13 | 1991-11-26 | Vipont Pharma | Oral rinse composition containing a benzophenanthridine alkaloid extract from sanguinaria canadesis |
EP0480996A1 (en) * | 1989-07-07 | 1992-04-22 | Atrix Laboratories, Inc. | Benzophenanthridine alkaloids for topical acne treatment |
JP2998287B2 (ja) * | 1991-03-13 | 2000-01-11 | 千寿製薬株式会社 | グリチルレチン酸誘導体 |
-
1992
- 1992-04-10 IT ITRM920270A patent/IT1254321B/it active
-
1993
- 1993-04-02 EP EP93830139A patent/EP0565495A1/en not_active Withdrawn
- 1993-04-05 CA CA002093401A patent/CA2093401A1/en not_active Abandoned
- 1993-04-06 US US08/043,493 patent/US5425948A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ITRM920270A1 (it) | 1993-10-10 |
CA2093401A1 (en) | 1993-10-11 |
US5425948A (en) | 1995-06-20 |
ITRM920270A0 (it) | 1992-04-10 |
EP0565495A1 (en) | 1993-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1254321B (it) | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. | |
IT8647603A0 (it) | Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita' | |
RU93047799A (ru) | Композиции, содержащие ретиноевые кислоты и токоферол | |
LU91125I2 (fr) | Ranélate den strontium et ses dérivés pharmaceutiquement acceptables (protelos). | |
MY108146A (en) | Medicaments for treating inflammatory conditions or for analgesia | |
IT1248588B (it) | Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari. | |
IL90056A (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
IT8721691A0 (it) | Derivati dell'ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide, loro procedimento di preparazione e loro impiegocome sostanze medicinali. | |
IT1151953B (it) | Composizione farmaceutica per la cura di affezioni della cavita' orale | |
IT1190471B (it) | Preparato per la cura e l'igiene della bocca | |
AU4265689A (en) | Treatment of periodontal disease using (3-benzoylphenyl) alkanoic acid derivatives | |
FR2613617B1 (fr) | Agents medicamenteux pour la prevention et la therapie des brulures cutanees par rayons, contenant comme principe actif la 2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine | |
CA2077693A1 (en) | Use of ketorolac for treatment of periodontal disease | |
CY2525B1 (en) | Use of penciclovir for the treatment of human herpes-virus-8 | |
IT1096279B (it) | Composto farmaceutico di migliorata attivita'mucolitica e fluidificante delle secrezioni mucose | |
IT1184287B (it) | Composizione per la preparazione di un medicamento da usare per la cura della piorrea alveolare | |
ITMI920525A1 (it) | Derivato dell'acido l-tiazolidin-4-carbossilico, sua preparazione e suo impiego terapeutico | |
IT8519776A0 (it) | Preparato per la cura esterna delle emorroidi. | |
ZA913511B (en) | New pharmaceutical use of benzocycloheptathiophene carboxylic acid derivatives | |
FR2602680B1 (fr) | Compositions pharmaceutiques pour l'administration par voie nasale | |
ITMI920041A0 (it) | Composizioni farmaceutiche somministrabili per via orale idrosolubili ed effervescenti e di gusto gradevole per il trattamento dell'ulcera | |
ITGE940025A0 (it) | Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi. | |
IT1257884B (it) | Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile. | |
LV5179A3 (lv) | Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai | |
IT8848258A0 (it) | Composizione farmaceutica per il trattamento delle affezioni parodontali |